Research: the third dose of the vaccine increases the level of antibodies in cancer patients
The third dose of the coronavirus vaccine significantly increases the antibody levels in the body of cancer patients.
This is evidenced by the results of a study conducted in the oncology department of the Ichilov hospital. The results are published in the Lancet Oncology.
According to scientists, more than 6 months after receiving the first two doses, antibody levels decline. Healthy patients and about 20% of cancer patients do not have antibodies after six months.
And the introduction of the third dose helps to significantly increase their levels. Most patients develop a positive immune response without significant side effects.
Related Posts
About The Author
Elizabeth
Elizabeth Stone has been a reporter on the news desk since 2013. Before that she wrote about young adolescence and family dynamics for Styles and was the legal affairs correspondent for the Metro desk. Before joining The Quebec Telegram, Elizabeth Stone worked as a staff writer at the Village Voice and a freelancer for Newsday, The Wall Street Journal, GQ and Mirabella. To get in touch, contact me through my stone@qtelegram.com 1-800-268-7116